Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.

Mats Ernofsson, Finn Strekerud, Henrik Toss, Ulrich Abildgaard, Lars Wallentin, Agneta Siegbahn, Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery disease. Thrombosis and Haemostasis. ,vol. 79, pp. 491- 494 ,(1998) , 10.1055/S-0037-1614931

G von der Lippe, L Wikstrom, IM Andersen, T Toftegaard-Nielsen, G Alsjo, J Kyst-Madsen, E Stahle, M Bertrand, E Svensson, GP Eriksson, H Wedel, M Gulin, SY Hassan, H Pilegaard, J Nordrehaug, B Lindvall, TT Nielsen, KA Jacobsson, S Persson, P Abrahamsson, A Holmgren, P Grande, G Lindstrom, E Stahl, T Seim, JE Nordrehaug, JD Nielsen, D Julian, G Setterberg, J Hulting, K Radegran, D Lindblom, M Arbeus, SL Ekstrom, H Saetre, O Geiran, T Jernberg, G Stenport, H Ohlin, H Bylund, G Frostfeldt, I Sjogren, A Rollag, B Andren, R Svedjeholm, T Kellerth, B Svane, L Wallentin, M Janzon, B Lindahl, S Husted, U Naslund, F Kontny, E Logander, E Swahn, B Lagerqvist, K Thygesen, E Diderholm, A Siegbahn, P Venge, M Dellborg, Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators The Lancet. ,vol. 354, pp. 701- 707 ,(1999)

B Adren, A Siegbahn, B Andren, E Swahn, R Nordlander, C Johansson, G Lindstrom, E Svensson, L Lundin, T Lundstrom, Å Hjalmarsson, E Karlsson, A Normark, K Wiklund, P Venge, L Wallentin, E Logander, G Almroth, F Landgren, H Saetre, E Enghoff, S Undeland, J Ohlsson, P Blomstrand, Low-molecular-weight heparin during instability in coronary artery disease The Lancet. ,vol. 347, pp. 561- ,(1996)

Richard C Becker, Frederick A Spencer, Youfu Li, Steven P Ball, Yunsheng Ma, Thomas Hurley, James Hebert, Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: Potential mechanisms for heightened prothrombotic potential Journal of the American College of Cardiology. ,vol. 34, pp. 1020- 1027 ,(1999) , 10.1016/S0735-1097(99)00322-8

Rikard Linder, Margareta Blombäck, Nils Egberg, Lars Grip, Thrombin inhibitors suppress the thrombin-thrombomodulin-mediated generation of activated protein C. Thrombosis Research. ,vol. 95, pp. 117- 125 ,(1999) , 10.1016/S0049-3848(99)00029-8

John-Bjarne Hansen, Per Morten Sandset, Differential Effects of Low Molecular Weight Heparin and Unfractionated Heparin on Circulating Levels of Antithrombin and Tissue Factor Pathway Inhibitor (TFPI): A Possible Mechanism for Difference in Therapeutic Efficacy Thrombosis Research. ,vol. 91, pp. 177- 181 ,(1998) , 10.1016/S0049-3848(98)00079-6

G. Di Tano, A. Mazzu, Early reactivation of ischaemia after abrupt discontinuation of heparin in acute myocardial infarction. Heart. ,vol. 74, pp. 131- 133 ,(1995) , 10.1136/HRT.74.2.131

Shaun G Goodman, Aiala Barr, Anatoli Sobtchouk, Marc Cohen, Gregg J Fromell, Luc Laperrière, Carol Hill, Anatoly Langer, Canadian Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) ST Segment Monitoring Substudy Group, Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy Journal of the American College of Cardiology. ,vol. 36, pp. 1507- 1513 ,(2000) , 10.1016/S0735-1097(00)00915-3

Eva Swahn, Lars Wallentin, Low-Molecular-Weight Heparin (Fragmin) During Instability in Coronary Artery Disease (FRISC) American Journal of Cardiology. ,vol. 80, ,(1997) , 10.1016/S0002-9149(97)00486-4

Maria Cecilia Bahit, Eric J Topol, Robert M Califf, Paul W Armstrong, Douglas A Criger, Vic Hasselblad, Amadeo Betriu, Jack Hirsh, Diego Ardissino, Christopher B Granger, Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb Journal of the American College of Cardiology. ,vol. 37, pp. 1001- 1007 ,(2001) , 10.1016/S0735-1097(01)01143-3